Related Experiment Video
Updated: Jul 21, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Predictability of serum digoxin concentrations in clinical practice.
This study examined how well doctors can predict blood levels of a heart drug called digoxin when patients are not taking another drug called quinidine. Researchers looked at factors like age, sex, and heart failure to see if they affected prediction accuracy. They tested four ways to estimate kidney function and four ways to estimate drug levels. The results showed that one prediction method had moderate accuracy, with correlation coefficients between 0.72 and 0.79. Age and heart failure did not affect prediction reliability. Female patients had slightly larger differences between predicted and actual levels, but this was not statistically significant. The study concluded that these prediction methods can be used reliably in typical clinical settings when quinidine is not involved.
Area of Science:
- Clinical pharmacology
- Cardiovascular medicine
- Pharmacokinetics
Background:
Estimating serum digoxin concentrations is important for managing patients on digoxin therapy. Prior research has shown that quinidine can alter digoxin levels, but less is known about other factors like age or heart failure. This gap motivated the current study to assess how reliable predicted concentrations are when quinidine is not involved. The study aimed to determine whether factors like age or congestive heart failure influence the accuracy of these predictions. Previous studies have used different methods to estimate creatinine clearance, but their impact on digoxin prediction remains unclear. This uncertainty drove the need for a focused analysis of prediction methods. No prior work had resolved whether sex or heart failure status affects digoxin prediction accuracy. The study sought to clarify these uncertainties in a clinical setting.
Purpose Of The Study:
The study aimed to evaluate the reliability of predicting serum digoxin concentrations without quinidine use. It focused on whether age, sex, or congestive heart failure affects prediction accuracy. Researchers wanted to determine if the method used to estimate creatinine clearance influences predicted values. The specific problem addressed was the lack of clarity about which factors impact digoxin prediction reliability. The motivation came from clinical needs to improve dosing accuracy in patients not taking quinidine. The researchers sought to test whether common estimation methods are sufficient for reliable predictions. They also aimed to assess whether sex differences affect prediction accuracy. The study aimed to provide evidence for clinical guidelines on digoxin use.
Main Methods:
The study included 44 patients who had been taking digoxin for ten consecutive days at a stable dose and route. Patients were required to have no quinidine use and stable renal function. They were categorized as having or not having congestive heart failure at the time of measurement. Four methods were used to estimate creatinine clearance, and four to estimate serum concentrations. Data were collected from patients representative of typical clinical populations. Predicted concentrations were compared to measured values using linear regression analysis. The study design ensured that all patients met strict inclusion criteria. The analysis focused on correlation coefficients to assess prediction reliability.
Main Results:
The study found that one prediction method had correlation coefficients ranging from 0.72 to 0.79, regardless of the creatinine clearance estimation method used. Age and congestive heart failure were not found to influence prediction reliability. Female patients showed a greater average difference between measured and predicted concentrations, but this was not statistically significant. The results suggest that prediction methods remain reliable in the absence of quinidine. The analysis confirmed that four different creatinine clearance methods did not affect prediction accuracy. No significant differences were found in predicted values based on age or heart failure status. The findings indicate that prediction methods can be used with acceptable accuracy in typical clinical settings. The results support the use of these methods for estimating digoxin concentrations.
Conclusions:
The authors concluded that serum digoxin concentrations can be predicted reliably when quinidine is not involved. They proposed that age, congestive heart failure, and common creatinine clearance estimation methods do not significantly affect prediction accuracy. The study suggests that prediction methods remain valid in typical clinical scenarios. The results indicate that sex differences in predicted concentrations are not statistically significant. The authors emphasized the importance of acknowledging method limitations when using predictions. They proposed that clinicians can rely on these methods for estimating digoxin levels. The findings support the use of prediction models in patients without quinidine co-administration. The study did not propose new clinical guidelines but validated existing estimation methods.
Frequently Asked Questions
The study found that predicted concentrations had correlation coefficients ranging from 0.72 to 0.79, indicating moderate reliability.
Yes, patients were categorized as having or not having congestive heart failure at the time of measurement.
To ensure stable dosing and route of administration, which is necessary for reliable concentration predictions.
Four different methods were used to estimate creatinine clearance in the study.
No, the study found that age did not significantly affect the reliability of predicted concentrations.
The authors proposed that these methods can be used reliably in clinical practice when quinidine is not involved.
Related Concept Videos
Dosage Regimens: Partial Pharmacokinetic Parameters
Dosage Regimen: Multiple Oral Dosage
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Pharmacodynamic Models: Linear Concentration–Effect Model
Pharmacodynamic Models: Logarithmic Concentration–Effect Model

